6 on Health: FluMist returning to market after being reformulated
FluMist, the nasal spray influenza vaccine, has been approved for the 2018-2019 season.
It's been off the market for two years because of its poor performance compared to the flu shot.
But the company that makes FluMist says it has reformulated the vaccine and tested it on 200 children. Company officials contend that it now works better.
An advisory committee that decides which vaccines make it to the U.S. agreed.
According to the Centers for Disease Control, 84 children have died as a result of influenza since the flu season began.
Three out of four children who died from the flu had not gotten a flu vaccine
The CDC recommends that everyone over the age of 6 months get a flu vaccine every year.